U.S., Sept. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07193589) titled 'A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis' on April 27.
Brief Summary: This clinical trial aims to explore whether the drug ZL-82 tablets can be used to treat moderate to severe atopic dermatitis in adults, and to understand the safety and tolerability of the drug. The main questions that the trial intends to answer are: Can ZL-82 tablets alleviate the Eczema Area and Severity Index (EASI) score of patients? What physical problems will patients have after taking ZL-82 tablets? The researchers will compare ZL-82 tablets with placebo (a substance with a similar appearance but without drug components) ...